Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/31/18 | 425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions |
|
3 | |
| 08/28/18 | 8-K | Current report filing |
|
139 | |
| 08/23/18 | 8-K | Current report filing |
|
3 | |
| 08/14/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 08/14/18 | 3 | Initial statement of beneficial ownership of securities |
|
3 | |
| 08/13/18 | 8-K | Current report filing |
|
6 | |
| 07/27/18 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
103 |
| 07/12/18 | 8-K | Current report filing |
|
10 | |
| 06/27/18 | 8-K | Current report filing |
|
36 | |
| 06/22/18 | 8-K | Current report filing |
|
6 |
